These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Sotalol and torsades de pointes ventricular tachycardia]. Petersen HH; Sandøe E Ugeskr Laeger; 1996 May; 158(19):2711-6. PubMed ID: 8744073 [TBL] [Abstract][Full Text] [Related]
24. Drug-induced QT prolongation: consequences and current dilemma. Dubrey SW; Grocott-Mason R Br J Hosp Med (Lond); 2007 Jan; 68(1):50-1. PubMed ID: 17260721 [No Abstract] [Full Text] [Related]
25. Proarrhythmic complications of sotalol. Campbell TJ Aust N Z J Med; 1996 Apr; 26(2):147-8. PubMed ID: 8744609 [No Abstract] [Full Text] [Related]
26. Torsades de pointes during low-dosage sotalol therapy in haemodialysis patients. Huynh-Do U; Wahl C; Sulzer M; Bühler H; Keusch G Nephrol Dial Transplant; 1996 Jun; 11(6):1153-4. PubMed ID: 8671988 [No Abstract] [Full Text] [Related]
27. ECG-based estimation of dispersion of APD restitution as a tool to stratify sotalol-induced arrhythmic risk. Mincholé A; Bueno-Orovio A; Laguna P; Pueyo E; Rodriguez B J Electrocardiol; 2015; 48(5):867-73. PubMed ID: 26117457 [TBL] [Abstract][Full Text] [Related]
28. JTc prolongation with d,l-sotalol in women versus men. Lehmann MH; Hardy S; Archibald D; MacNeil DJ Am J Cardiol; 1999 Feb; 83(3):354-9. PubMed ID: 10072223 [TBL] [Abstract][Full Text] [Related]
29. Sotalol associated torsades de pointes tachycardia in a 15-month-old child: successful therapy with magnesium aspartate. Sasse M; Paul T; Bergmann P; Kallfelz HC Pacing Clin Electrophysiol; 1998 May; 21(5):1164-6. PubMed ID: 9604253 [TBL] [Abstract][Full Text] [Related]
30. Amiodarone versus sotalol for atrial fibrillation. Zimetbaum PJ; Josephson ME N Engl J Med; 2005 Aug; 353(6):627-30; author reply 627-30. PubMed ID: 16094764 [No Abstract] [Full Text] [Related]
31. Monotherapy versus combination therapy with class III antiarrhythmic agents to attenuate transmural dispersion of repolarization: a potential risk factor for torsade de pointes. Shah SA; Kluger J; White CM Pharmacotherapy; 2007 Sep; 27(9):1297-305. PubMed ID: 17723083 [TBL] [Abstract][Full Text] [Related]
32. Torsade de pointes and prolonged QT interval from surreptitious use of sotalol: use of drug levels in diagnosis. Link MS; Foote CB; Sloan SB; Homoud MK; Wang PJ; Estes NA Chest; 1997 Aug; 112(2):556-7. PubMed ID: 9266902 [TBL] [Abstract][Full Text] [Related]
33. [Sotalol-induced torsade de pointes tachycardia in a 15-month-old infant]. Sasse M; Paul T; Bergmann P; Kallfelz HC Z Kardiol; 1995 Oct; 84(10):863-6. PubMed ID: 7502575 [TBL] [Abstract][Full Text] [Related]
34. Torsades de pointes following cardioversion: case history and literature review. Spearritt D Aust Crit Care; 2003 Nov; 16(4):144-9. PubMed ID: 14692159 [TBL] [Abstract][Full Text] [Related]
35. Sustained torsade de pointes occurring early during oral sotalol therapy for atrial fibrillation recurrence prophylaxis in a patient without heart disease. D'Aloia A; Faggiano P; Brentana L; Boldini A; Pedrinazzi C; Procopio R; Dei Cas L Int J Cardiol; 2005 Dec; 105(3):337-9. PubMed ID: 15985302 [TBL] [Abstract][Full Text] [Related]
36. A/H1N1 flu. Time for case-control studies of NSAIDs and oseltamivir. Herxheimer A; Clarke M; Edwards R; Jefferson T; Loke Y BMJ; 2009 Jul; 339():b3048. PubMed ID: 19638383 [No Abstract] [Full Text] [Related]
37. Oseltamivir-induced mania in a patient with H1N1. Ho LN; Chung JP; Choy KL Am J Psychiatry; 2010 Mar; 167(3):350. PubMed ID: 20194491 [No Abstract] [Full Text] [Related]
38. Engineering experience and clinical electrocardiography. Malik M J Electrocardiol; 2015; 48(5):900-1. PubMed ID: 26253985 [No Abstract] [Full Text] [Related]
39. [Torsade de pointe resulting from a drug interaction between sotalol and ciprofloxacin]. Devaux F; Fillet M; Krzesinski F Rev Med Liege; 2019 Jul; 74(7-8):382-387. PubMed ID: 31373450 [TBL] [Abstract][Full Text] [Related]